中国口腔医学继续教育杂志 ›› 2025, Vol. 28 ›› Issue (6): 451-459.DOI: 10.12337/zgkqjxjyzz.2025.06.011

• 病例报告 • 上一篇    下一篇

多学科联合诊疗口腔红白斑1例

董馨怡, 李敏, 王柳, 卢珊, 陈方淳*   

  1. 重庆医科大学附属口腔医院口腔黏膜科,口腔疾病研究重庆市重点实验室,口腔生物医学工程重庆市高校市级重点实验,重庆市卫生健康委口腔生物医学工程重点实验室
  • 出版日期:2025-11-30 发布日期:2025-11-30
  • 通讯作者: *陈方淳,联系方式:023-88602370,电子邮箱:40446055@qq.com,通讯地址:重庆市两江新区松石北路426号,401147

A Case of Oral Erythroleukoplakia Managed by Multidisciplinary Team

Xinyi Dong, Min Li, Liu Wang, Shan Lu, Fangchun Chen*   

  1. Department of Oral Medicine, Stomatological Hospital of Chongqing Medical University, Chongqing Key Laboratory of Oral Diseases Research, Chongqing Municipal Key Laboratory of Oral Biomedical Engineering (Higher Education Institutions), Key Laboratory of Oral Biomedical Engineering, Chongqing Municipal Health Commission
  • Online:2025-11-30 Published:2025-11-30
  • Contact: Fangchun Chen. Tel: 023-88602370. Email: 40446055@qq.com. Address: 426 Songshibei Road, Liangjiang New Area, Chongqing 401147, P.R. China.

摘要: 目的:探讨多发性口腔红白斑的多学科联合管理方案及长期预后。诊治经过:对1例69岁女性多发性口腔红、白斑进行长达7年的规范化诊疗及随访,通过组织病理学活检、无创检测技术等完善相关检查,动态监测病情变化,根据病变风险分层动态调整治疗方案,采取光动力及手术治疗,兼顾病变控制、功能保存与患者生活质量。结果:患者历经病情好转-复发-新发-稳定的复杂过程,经多学科协作及个体化治疗后,口腔红白斑病变长期控制稳定,未发生恶变,口腔功能及生活质量得到最大程度保障。值得关注的是,患者后期因患膀胱癌行丝裂霉素局部灌注化疗,口腔白斑意外消失。结论:多学科联合诊疗及风险分层管理是口腔红白斑患者预后的关键,化疗后口腔白斑消失为药物治疗提供新思路。

关键词: 口腔红白斑, 多学科联合诊疗, 光动力治疗, 风险分层管理, 丝裂霉素

Abstract: Objective: To explore the multidisciplinary collaborative management protocol and long-term prognosis of multiple oral erythroleukoplakia. Diagnosis and Treatment: A 69-year-old female patient with multiple oral erythroleukoplakia underwent standardized diagnosis, treatment, and follow-up for 7 years. Comprehensive examinations including pathological biopsy, non-invasive detection technologies were performed to dynamically monitor disease progression. A multidisciplinary team (MDT) comprising specialists from the Department of Oral Mucosal Diseases, Department of Oral and Maxillofacial Surgery, and Department of Pathology collaborated to dynamically adjust treatment strategies based on lesion risk stratification, balancing lesion control, functional preservation, and the patient’s quality of life. Results: The patient experienced a complex clinical course characterized by improvement, recurrence, development of new lesions, and eventual stabilization. Following multidisciplinary collaboration and individualized treatment, long-term stable control of oral erythroleukoplakia was achieved without malignant transformation, oral function and the patient’s quality of life were maximally preserved. Notably, the patient underwent local perfusion chemotherapy with mitomycin due to bladder cancer in the later stage, and the oral leukoplakia disappeared accidentally. Conclusions: Close and regular follow-up, MDT, and risk-stratified management are crucial for improving the prognosis of patients with oral erythroleukoplakia. This study provides a reference for the clinical management of complex oral potentially malignant disorders(OPMDs). The disappearance of oral leukoplakia after chemotherapy provides new ideas for drug treatment.

Key words: oral erythroleukoplakia, multidisciplinary collaboration, photodynamic therapy, risk-stratified management, mitomycin